DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Online

The Future of Clinical Trial Transparency – 3 Trends for 2021

Presenters

Niamh Catherine McGuinness, PHD

Niamh Catherine McGuinness, PHD

Director, Pharma Solutions, IQVIA Applied AI Science, IQVIA, United States

Niamh McGuinness is Director of Pharma Solutions with the Applied AI Science Team in IQVIA. Niamh leads a diverse group of experts who build AI solutions and utilize a suite of award-winning technology to help pharma customers protect participant privacy and surface critical insights from unstructured data and literature, for a vast array use cases from bench to bedside, including R&D, drug safety and medical affairs. Niamh has been with IQVIA for 8 years. She received her PhD in neuroimmunology from Trinity College, Dublin.

Peter  Mesenbrink, PHD

Peter Mesenbrink, PHD

Executive Director of Biostatistics, Novartis Pharmaceuticals Corporation, United States

Peter Mesenbrink, PhD is an Executive Director of Biostatistics at Novartis Pharmaceuticals Corporation in East Hanover, New Jersey. Peter received his BS in Mathematics from UVM in 1989 and a PhD in Statistics from NCSU in 1995. He joined Novartis in 1995 and is currently Therapeutic Area Head of Biostatistics for Rheumatology. He is an active member and leader within IMI EU-PEARL. Peter has research interests in statistical methodology for estimands/handling of missing data, design of master protocols, and meta-analysis methods. He is currently on the Board of Directors for the Clinical Research Data Alliance to improve how we share data within the scientific community.

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。